Építés alatt – nem éles oldal
Belépés

Gyomor- és nyelőcsőrák trials, also abroad

1483 open Gyomor- és nyelőcsőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína724
Egyesült Államok274
Dél-Korea88
Franciaország80
Olaszország71
All other countries

The same trial often runs in several countries

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer has 9 sites in Brazília and runs in 28 countries. If a site near you is full, another one may still take people.

See A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer in all 28 countries
Építés alatt, nem éles – Gyomor- és nyelőcsőrák: vizsgálatok itt: Brazília – Frontlight Research